Archive

Volume 24/2, December 2022, pp. 229-235 |  PDF Yara Asi,* Weeam Hammoudeh,* David Mills,* Osama Tanous,* and Bram Wispelwey* In health as in many disciplines, too often the perspectives and framings of the very populations in question are…

Volume 24/2, December 2022, pp. 219-228 |  PDF Kaitlin Fajber Abstract This essay examines the extent to which COVID-19 Vaccines Global Access (COVAX) has been a successful mechanism for global COVID-19 vaccine equity as a component of the…

Volume 24/2, December 2022, pp. 215-218 |  PDF Paul Hunt and Sophie Bradwell-Pollak New Zealand has a well-deserved positive reputation for its handling of the COVID-19 crisis. The early closure of the country’s border in March 2020, combined…

Volume 24/2, December 2022, pp. 211-214 |  PDF Ellen ‘t Hoen The scrambling for access to COVID-19 vaccines by developing countries has reignited the debate on the World Trade Organization’s (WTO) Agreement on Trade-Related Aspects of…

Volume 24/2, December 2022, pp. 205-209 |  PDF Rosalind Turkie Introduction Pharmaceutical companies have the power and the responsibility to help governments realize the human right to health for all, yet there are egregious…

Volume 24/2, December 2022, pp. 191-204 |  PDF Katrina Perehudoff and Jennifer Sellin Abstract Facing the unmet need for new, affordable medicines for public health crises, how should states’ duty to ensure that everyone shares in the…